Fulltext

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

Van Cutsem, E. ; Hoff, P. M. ; Blum, J. L. ; Abt, M. ; Osterwalder, B.

In: Annals of Oncology, 2002, vol. 13, no. 3, p. 484-485

Add to personal list
    Title
    • Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil
    Author
    • Van Cutsem, E.. University Hospital Gasthuisberg, Leuven, Belgium (E-mail: eric.vancutsem@uz.kuleuven.ac.be)
    • Hoff, P. M.. Centro Paulista de Oncologia, Albert Einstein Hospital, Sâo Paulo, Brazil
    • Blum, J. L.. Baylor-Charles A. Sammons Cancer Center, US Oncology, Dallas, Texas, USA
    • Abt, M.. Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland
    • Osterwalder, B.. Clinical Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland (E-mail: eric.vancutsem@uz.kuleuven.ac.be)
    Document Type
    • Postprint
    Language
    • English
    Published in
    • Annals of Oncology, 2002, vol. 13, no. 3, p. 484-485. Oxford University Press
    Other Version
    Classification
    • Health
    OAI-PMH Identifier
    • oai:doc.rero.ch:297408